HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.

AbstractOBJECTIVE:
We determine if action potential duration (APD) shortening and cardioprotection are separable phenomena in ATP-sensitive potassium channel (KATP) openers which protect ischemic myocardium via a glyburide-reversible mechanism.
METHODS:
We determined the effect of the weakly vasodilating KATP opener, BMS-180448, and the less cardiac-selective cromakalim, on APD in normal, hypoxic or ischemic guinea pig papillary muscles or isolated hearts and compared their APD effects with their cardioprotective activity in isolated guinea pig hearts.
RESULTS:
In isolated ischemic guinea pig hearts, cromakalim and BMS-180448 had similar cardioprotective potencies (EC25 of 3.2 and 3.3 microM, respectively, for increasing time to the onset of contracture). At 10 microM, BMS-180448 produced no APD shortening, yet was equally protective at this concentration compared to cromakalim, which produced profound APD shortening under either hypoxic or ischemic conditions. The cardioprotective effects of both compounds at 10 microM were abolished by 0.3 microM glyburide.
CONCLUSIONS:
APD shortening is not correlated with cardioprotective activity for BMS-180448 and cromakalim while their cardioprotective effects are abolished by glyburide. These results suggest the possibility of reduced proarrhythmic activity in some KATP openers and that their cardioprotective activity is not associated with sarcolemmal KATP opening.
AuthorsG J Grover, A J D'Alonzo, T Hess, P G Sleph, R B Darbenzio
JournalCardiovascular research (Cardiovasc Res) Vol. 30 Issue 5 Pg. 731-8 (Nov 1995) ISSN: 0008-6363 [Print] England
PMID8595620 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Benzopyrans
  • Guanidines
  • Potassium Channels
  • Pyrroles
  • Vasodilator Agents
  • Cromakalim
  • Adenosine Triphosphate
  • BMS 180448
  • Glyburide
Topics
  • Action Potentials (drug effects)
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Benzopyrans (pharmacology)
  • Cromakalim
  • Female
  • Glyburide (pharmacology)
  • Guanidines (pharmacology)
  • Guinea Pigs
  • In Vitro Techniques
  • Ion Channel Gating (drug effects)
  • Male
  • Membrane Potentials (drug effects)
  • Myocardial Infarction (prevention & control)
  • Myocardial Ischemia (metabolism)
  • Perfusion
  • Potassium Channels (drug effects)
  • Pyrroles (pharmacology)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: